{"id":"W2057416509","doi":"10.2174/13816128113199990313","title":"Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies","year":2013,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"Core Research for Evolutional Science and Technology; Canadian Institutes of Health Research; Pfizer","keywords":"PCSK9; Kexin; Proprotein convertase; Subtilisin; Familial hypercholesterolemia; Medicine; LDL receptor; Proprotein Convertases; Pharmacology; Cholesterol; Chemistry; Endocrinology; Biochemistry; Lipoprotein; Enzyme","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001195213,0.000568003,0.00204649,0.0001958943,0.00004796069,0.00004003907,0.0001934939,0.0003017653,0.00005370906],"category_scores_gemma":[0.00008873308,0.0002901809,0.0005986502,0.0002545725,0.0003166629,0.00005444403,0.00004178829,0.0006328674,0.00004925959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001966851,"about_ca_system_score_gemma":0.0003314793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003994208,"about_ca_topic_score_gemma":9.755499e-7,"domain_scores_codex":[0.9961129,0.001453808,0.0008725103,0.0005746626,0.000515767,0.0004703483],"domain_scores_gemma":[0.9985332,0.0002937139,0.0001999768,0.0006879349,0.00005670494,0.0002284835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005539281,0.0007820087,0.00007046871,0.01407465,0.0001336419,0.00006242326,0.0002758175,1.359773e-7,0.00001199534,0.00003067478,0.0001550861,0.9843477],"study_design_scores_gemma":[0.001872635,0.0008621243,0.00004210015,0.006934733,0.001546242,0.0002035091,0.00005095871,0.00002884833,0.0002898402,0.0000242244,0.9878772,0.000267596],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001351019,0.9892235,0.0001526234,0.00008771894,0.0002232595,0.008834194,0.00004597924,0.00003243241,0.00004924611],"genre_scores_gemma":[0.0006942348,0.9968863,0.0002326119,0.0001005155,0.0003107037,0.00166158,0.00003283462,0.00005622952,0.00002506267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9877221,"threshold_uncertainty_score":0.9999551,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2804797153982914,"score_gpt":0.4420727696308272,"score_spread":0.1615930542325358,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}